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Abstract A sub-gene encoding the catalytic (acetyltransferase) 
domain (E2pCD) comprising residues 173-427 of the dihydro-
lipoyl acetyltransferase (E2p) chain of the pyruvate dehydrogen-
ase multienzyme complex of Bacillus stearothermophilus was 
expressed in Escherichia coli. The product assembled to form the 
characteristic icosahedral (60-mer) core structure with full 
catalytic activity. The Km values for dihydrolipoamide and 
acetyl-CoA were 1.2 mM and 13 jiM, respectively. Dissociation 
of the icosahedral E2pCD into monomers by exposure to 
guanidine hydrochloride and the subsequent reassociation by 
gradual removal of the denaturing agent demonstrated the ability 
of the polypeptide chain to fold and reassemble in the absence of 
chaperonins. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The 2-oxo acid dehydrogenase complexes consist of multi-
ple copies of three enzymes which together catalyse the oxi-
dative decarboxylation of 2-oxo acids. The complexes are as-
sembled around an oligomeric dihydrolipoyl acyltransferase 
(E2) core to which the 2-oxo acid decarboxylase (El) and 
dihydrolipoyl dehydrogenase (E3) components are bound 
tightly, but non-covalently [1^1]. The E2 components are 
found in two different symmetries, octahedral or icosahedral, 
depending on the source. The octahedral E2 consists of 24 
identical polypeptide chains arranged with 432 symmetry, gen-
erating a cube-like structure with each vertex composed of 
three, and each face of four, E2 chains. The icosahedral E2 
consists of 60 E2 chains arranged with 532 symmetry to gen-
erate a pentagonal dodecahedron. Each vertex is again com-
posed of three E2 chains and each face of five E2 chains. The 
intact multienzyme complexes have molecular masses in the 
range of 1-10 XlO6 Da, and as such are easily visible in the 
electron microscope [5-7] where the different symmetries can 
be identified. 
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The mechanistic core of the 2-oxo acid dehydrogenase com-
plexes is also provided by the E2 component. The N-terminal 
region of each E2 chain consists of one, two or three lipoyl 
domains, each approximately 80 amino acids in length, de-
pending upon the species. The lipoyl domains are tandemly 
arrayed, being joined by flexible linker peptides approximately 
25-30 amino acids long, rich in alanine, proline and charged 
amino acids. The lipoyl domains are followed by another 
domain, about 35 amino acids in length, the main function 
of which lies in binding E3 dimers to the E2 core. In icosahe-
dral PDH complexes, such as that from Bacillus stearothermo-
philus [8,9], this domain also serves as a major contributor to 
the pyruvate decarboxylase (Elp)-binding site [4]. The periph-
eral subunit-binding domain is in turn joined by another link-
er peptide to a large (29 kDa) C-terminal domain. This 
C-terminal region aggregates to form the inner (octahedral 
or icosahedral) core structure of the 2-oxo acid dehydrogenase 
complexes and also contains the active site for the acyltrans-
ferase reaction. 
X-ray crystallography of the octahedral (24-mer) complex 
of the catalytic domain of Azotobacter vinelandii dihydrolipoyl 
acetyltransferase (E2p) has produced a high resolution struc-
ture and thrown light on the mode of assembly and catalytic 
activity [10,11]. In this paper, we describe the creation of a 
sub-gene encoding the catalytic domain from B. stearothermo-
philus E2p. We have been able to express this sub-gene in 
Escherichia coli, thereby permitting the purification and char-
acterization of the icosahedral assembly. The icosahedral 
structure, with full catalytic activity, can be reassembled 
from monomers after denaturation in vitro with guanidine 
hydrochloride and subsequent removal of the denaturing 
agent. 
2. Materials and methods 
2.1. Materials 
Bacterological media were from Difco. The pKKE2 vector carrying 
the dihydrolipoyl acetyltransferase gene that encodes residues 1^ 427 
of B. stearothermophilus E2p [12] was generated earlier (A. Borges, 
C.F. Hawkins and R.N. Perham, unpublished work). Plasmid pETlld 
and E. coli host strain BL21(DE3) [(F~, ompT, hsdSy, (rb~, mi,~), gal, 
dcm, (DE3)] were obtained from Novogen Inc. Dihydrolipoamide was 
synthesized from lipoamide by reduction with sodium borohydride 
[13]. 
2.2. Recombinant DNA techniques 
Small DNA fragments were isolated from agarose gels by using the 
Magic miniprep purification systems (Promega). Dideoxynucleotide 
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Fig. 1. Purification of E2pCD, as judged by SDS-polyacrylamide gel 
electrophoresis. Lanes 1 and 7: MT standards (ovotransferrin 77000, 
BSA 66000, ovalbumin 45000, carbonic anhydrase 29000, myoglo-
bin 17000, cytochrome c 12300). Lane 2: Soluble fraction from dis-
rupted E. coli cells previously transformed with pETHE2pCD and 
grown for 3 h after induction with IPTG. Lane 3: 30-55% ammo-
nium sulfate fraction. Lane 4: Protein eluted from Hi-load Q col-
umn. Lane 5: Protein eluted from Superose 6 column. Lane 6: Pro-
tein eluted from Mono Q column. 
DNA sequencing [14] was carried out using the T7 sequencing kit 
from Pharmacia and [o>35S]dATP from Amersham International. Po-
lymerase chain reactions (PCR) [15,16] were carried out under mineral 
oil in a reaction buffer (100 ul) containing 100 pmol of each sense and 
antisense primer, and 2.5 U of Taq polymerase on a programmable 
PHC-3 thermal cycler (Techne Corp.). The cycling parameters were as 
follows: 3 min at 94°C (one cycle); and 1 min at 94°C, 2 min at 55°C 
and 3 min at 72°C (25 cycles). The fidelity of the amplified PCR 
fragments was established by DNA sequencing after sub-cloning 
into the vector. 
2.3. Construction of expression vector pETHE2pCD 
The DNA sequence encoding the C-terminal catalytic domain (res-
idues 173^127) of the B. stearothormophilus E2p was amplified from 
plasmid pKKE2 by PCR using a 24-bp sense oligonucleotide (5'-
GGCGGCGCAACCATGGCACCGGCC-3'; mismatches under-
lined) and a 27-bp antisense oligonucleotide (5'-TTCGGATC-
CATCGTTTTACGCCTCCATT-3'). The PCR product (798 bp) 
was digested with Nco\ and BamHl, purified by agarose gel electro-
phoresis and sub-cloned into the pETlld vector previously digested 
with Ncol and BamHl and treated with calf intestinal alkaline phos-
phatase. 
2.4. Gene expression and purification of E2pCD 
E. coli strain BL21(DE3) cells were transformed with pETl lE2pCD 
and grown to an Agoo of 1.0 in 2X YT medium [17] supplemented with 
ampicillin (100 uM) before induction with IPTG (1 mM). The cells 
were harvested 4 h after induction and resuspended in 50 mM Tris-
HC1 buffer, pH 7.5, containing 1 mM EDTA, 1 mM PMSF, 0.02% 
NaN3 and 0.1 mg/ml RNAse. The suspension was incubated for 
30 min at room temperature and then disrupted in a French press. 
After centrifugation (130000Xg for 20 min), the supernatant was 
subjected to fractional precipitation with (NH4)2S04. The precipitate 
that formed between 30 and 55% saturation was dissolved in buffer A 
(20 mM potassium phosphate, pH 7.0, containing 0.02% NaNs), dia-
lysed against the same buffer, and applied to a Hi-load-Q column 
(Pharmacia) equilibrated with buffer A. E2pCD was eluted with buff-
er B (20 mM potassium phosphate, pH 7.0, 1 M NaCl, 0.02% NaN3) 
applied as a 0-100% gradient over four column volumes. Fractions 
containing E2pCD (as identified by SDS-PAGE using a Tris/Tricine 
buffer system [18]) were pooled and gel-filtered on a Superose 6 HR 
(10/30) column (Pharmacia) equilibrated with buffer A. Fractions 
containing E2pCD were applied to a Mono-Q column (Pharmacia) 
equilibrated with buffer A, and the E2pCD was eluted with buffer B 
applied as a 0-100%) gradient over four column volumes. The purity 
of the E2pCD was confirmed by N-terminal sequence analysis. 
2.5. Measurement of E2p catalytic activity 
The catalytic activity of E2p was assayed (increase in A240 corre-
sponding to formation of acetyldihydrolipoamide) at 30°C under the 
following conditions [19]: 85 mM Tris-HCl, pH 8.0, 10 mM acetyl 
phosphate, 0.24-10.4 mM dihydrolipoamide, 5-200 uM Co A, phos-
photransacetylase (2 U/ml). 
2.6. Electron microscopy of E2pCD 
A drop of the protein sample (0.1 mg/ml) was placed on a Formvar 
and carbon-coated copper grid, and the excess removed by touching 
with filter paper. The grid was dried and negatively stained with 1% 
(w/v) phosphotungstic acid buffered with 100 mM potassium phos-
phate, pH 7.0, and inspected in a Philips EM 301 electron microscope. 
2.7. Dissociation and reconstitution of E2pCD 
Samples of B. stearothermophilus E2pCD or bovine serum albumin 
(BSA) were incubated for 1 h in buffer A (50 mM potassium phos-
phate, pH 7.0) containing a range of concentrations (50 mM to 6 M) 
of guanidine hydrochloride (GuHCl). Each sample of E2pCD was gel-
filtered through a Superose 6 (HR) column pre-equilibrated with the 
relevant incubation buffer. Comparison of the elution positions for 
BSA and E2pCD was used to calibrate the dissociation of the 
(60-mer) E2pCD core complex (Afr = 1.8 MDa) into monomers 
(Afr = 28 kDa). 
A separate sample of B. stearothermophilus E2pCD was subse-
quently incubated for 1 h in buffer A (50 mM potassium phosphate, 
pH 7.0) containing 6 M GuHCl and 1 mM DTT and gel-filtered 
through a Superose 6 (HR) column in the same solution. The pooled 
fractions containing E2pCD were dialysed successively against buff-
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Fig. 2. Dissociation of icosahedral B. stearothermophilus E2pCD in-
duced by GuHCl, as judged by gel filtration. Samples of B. stearo-
thermophilus E2pCD (1 nmol) dissolved in 50 mM potassium phos-
phate, pH 7.0, containing increasing concentrations of GuHCl were 
subjected to gel filtration on a Superose 6 (HR) column equilibrated 
with the relevant GuHCl-containing buffer (solid line). BSA exam-
ined under identical conditions was used as a molecular mass 
marker (dotted line). 
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er A containing 1 mM DTT and supplemented in turn with 4, 3, 2, 
1.5, 1.0, 0.7, 0.5, 0.3, 0.2 and 0.1 M GuHCl (2 h for each dialysis). 
The final dialysis was against buffer A without DTT. The resulting 
solution was then gel-filtered through a Superose 6 (HR) column 
equilibrated with buffer A to determine the elution position of the 
reconstituted E2pCD. 
3. Results 
Expression in E. coli of a sub-gene encoding residues 173— 
427 of the B. stearothermophilus E2p polypeptide chain was 
successfully achieved, enabling the B. stearothermophilus 
E2pCD complex to be purified in high yield (Fig. 1). The 
protein displayed the high molecular mass, as judged subse-
quently by gel filtration (Fig. 2) and the appearance in the 
electron microscope (Fig. 3), expected of an icosahedral (60-
mer) aggregate. 
The catalytic activity of the truncated E2p component, 
which should contain the acetyltransferase active site, was 
measured in the reverse physiological direction [19]. Double-
reciprocal plots (1/v vs. 1/S) of the initial velocity data were 
linear, converging at a point close to the x-axis. Secondary 
plots of the intercepts on the >>-axis against the reciprocal of 
the fixed substrate concentration were also linear. The Km 
values for dihydrolipoamide and acetyl-CoA were estimated 
as 1.2 mM and 13.0 u,M, respectively. The convergence of the 
double-reciprocal plots at a point on the x-axis suggests the 
bi-substrate reaction proceeds via a sequential mechanism. 
The bovine kidney E2p component was previously shown to 
follow a random sequential mechanism [20]. 
The ability of E2pCD to bind the Elp and E3 components 
of the B. stearothermophilus PDH complex was assessed by 
gel-filtering E2pCD with various admixtures of recombinant 
Elp and E3 [[28]; A. Borges, C.F. Hawkins and R.N. Per-
ham, unpublished work] in 20 mM postassium phosphate 
buffer, pH 7.0, on a Superose 6 (HR) column. No evidence 
of interaction was observed, confirming the conclusions from 
limited proteolysis of the native PDH complex, which sug-
gested that the peripheral subunit-binding domain of B. stea-
rothermophilus E2p plays a major part in binding both Elp 
and E3 [4]. 
Samples of E2pCD were incubated for 1 h in 50 mM po-
tassium phosphate, pH 7.0, containing various concentrations 
of GuHCl. Each sample was then gel filtered on a Superose 6 
gel-filtration column in the same solution (Fig. 2), with BSA 
(molecular mass 66 kDa) used as a standard. In the absence of 
GuHCl, E2pCD was eluted as a high molecular mass species, 
Fig. 3. Reassembly of icosahedral B. stearothermophilus E2pCD after dissociation with GuHCl. a: B. stearothermophilus E2pCD was incubated 
in 50 mM potassium phosphate, pH 7.0, containing 6 M GuHCl and 1 mM DTT for 1 h and the dissociation of the 60-mer structure was ana-
lysed by gel filtration on a Superose 6 (HR) column in the same solution. After gradual dialysis back into 50 mM potassium phosphate, 
pH 7.0, the E2pCD was gel filtered in the same buffer to assess the reassociation into an icosahedral complex, b: Electron micrograph of 
the E2pCD before dissociation in GuHCl. c: Electron micrograph of the E2pCD after dissociation in GuHCl and reassembly. 
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consistent with an icosahedral aggregate of the polypeptide 
chain (Fig. 2a). BSA began to unfold when incubated in 
1.5 M GuHCl, as evidenced by an increase in the hydrody-
namic radius and earlier elution from the column (Fig. 2c). 
E2pCD also began dissociating/unfolding at 1.5 M GuHCl, 
with a small peak appearing in a position consistent with a 
lower molecular mass than that of unfolded BSA. When the 
concentration of GuHCl reached 2.5 M, all the 60-mer com-
plex was found to be dissociated into the smaller component 
(Fig. 2e), with no further change in elution profile when the 
concentration of GuHCl was raised to 6 M. 
The apparent molecular mass of the dissociated E2pCD 
was estimated to be approximately 30 kDa, corresponding 
to the monomeric polypeptide chain. The formation of an 
intermediate trimeric species in the analytical ultracentrifuge 
has been described [21,22], but no corresponding peak was 
observed in the present experiments. Previous fluorimetric 
studies [23] of the icosahedral bovine heart PDH complex 
have also suggested that the 60-mer and trimeric E2p species 
dissociate into monomers, with 50% loss of tertiary structure 
at 1.9 M GuHCl and 50% loss of secondary structure at 2.8 M 
GuHCl. 
The ability of E2pCD to reassociate from the unfolded state 
was also examined (Fig. 3a). E2pCD was incubated for 1 h in 
50 mM potassium phosphate, pH 7.0, containing 1 mM DTT 
and 6 M GuHCl. The unfolded E2pCD was gel filtered 
through a Superose 6 column in the same solution and the 
fractions containing the unfolded E2pCD chain were col-
lected. The pooled fractions were dialysed gradually into 
50 mM potassium phosphate buffer, pH 7.0, as described in 
Section 2, and the protein was then subjected to gel filtration 
on a Superose 6 column equilibrated with the same buffer. It 
was found to have assembled into a complex that was eluted 
in a position identical to that of native E2pCD. 
Electron microscopy of the refolded E2pCD (Fig. 3c) re-
vealed the presence of icosahedral complexes identical to 
those observed before dissociation (Fig. 3b) and the acetyl-
transferase activity of the refolded E2pCD was found to have 
regained 95% of its original value. Interestingly both the na-
tive and refolded E2pCD complexes appear capable of form-
ing small amounts of structures larger than the 60-mer com-
plexes, as evidenced by a small peak emerging near the 
exclusion volume of the column. This suggests some degree 
of aggregation of E2pCD in low ionic strength buffers, an 
observation also made in the electron microscope (Fig. 3b). 
4. Discussion 
Previous studies of dissociation and refolding of the E2 
components of various other PDH complexes have also re-
ported full recovery of activity after unfolding [21,24], but 
some have obtained only partial activity [25], or no activity 
at all [22] after denaturation. In Saccharomyces cerevisiae, the 
folding of the mitochondrial E2p precursors in vivo is thought 
to be mediated by interaction with chaperonins homologous 
to dnaK, dnaJ, GroEL, GorES and grpE found in E. coli [26]. 
It has also been reported that in vitro assembly of the hetero-
tetrameric (0C2P2) El component and octahedral (24-mer) E2 
core domain (E2bCD, residues 161^421) of the bovine 
branched chain 2-oxo acid dehydrogenase complex relies on 
chaperonins GroEL and GroES [22,27]. However, it is evident 
from the experiments reported above that chaperonins are not 
absolutely essential for the in vitro refolding and assembly of 
the B. stearothermophilus E2pCD core complex, nor are they 
essential for the in vitro assembly of its El (0:2(^ 2) component 
[28]. These differences between homologous E2p cores from 
different species will repay further study. 
Crystallization of an intact E2 component from a 2-oxo 
acid dehydrogenase multienzyme complex has so far proved 
unsuccessful, probably because of the presence of flexible link-
ers between the domains in the E2 chains. However, over-
expression of a sub-gene encoding the catalytic domain of 
the A. vinelandii E2p component has enabled the X-ray crys-
tallographic analysis of an octahedral E2 core [10,11]. Over-
expression of sub-gene encoding the catalytic domain of the 
B. stearothermophilus E2p component described in this paper 
demonstrates the self-assembly of an icosahedral core and 
paves the way to the determination of its crystal structure. 
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